Fitness Apps Challenge Personal Trainer Industry Market Disruption or Complementary Tool NYT Pips Puzzle Walkthrough Released What It Means for Subscriber Engagement Nerdy NRDY Falls 145 Watching 078 Support 20260515 Financial Services Roundup Market Talks Highlight Key Trends for SoFi Technologies and Experian DR Horton DHI Q1 2026 Earnings Shine Revenue Growth Fuels Beat SpaceX IPO Filing Omits China as Market Target Flags Geopolitical Risk United UHG Q4 2025 In Line Whats Next for Investors Myndai MYND Stock Analysis Falls 728 Watching 027 20260521 Universal Health Services Analysts Weigh In on Hospital Operators Prospects Asian Markets Track Wall Streets Record Highs Oil Prices Retreat Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project DeepSeek Fears Overblown US AI Titans Remain Resilient UK Police to Assess Train Operators on Sexual Harassment Measures but No Penalties for NonCompliance Dollar Slips Oil Retreats Amid Growing Hopes for Hormuz Stability JBG SMITH Properties JBGS Q1 2026 Earnings Modest Profit Amid Continued Portfolio Transition Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction Commercial Metals Company CMC Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Resilient Demand Mesabi Trust MSB Q1 2026 Earnings Iron Ore Royalty Income Pressures Net Income Shares Decline Vodafone Q4 2025 Earnings EPS Beat of 4078 Surprises but Stock Slips on Cautious Outlook AlTi Global Q1 2026 Earnings EPS Surges Past Estimates by 3072 Stock Drops 462 COST Q1 2026 Earnings EPS Misses Estimates Amid Margin Pressures Stock Declines BTU Q1 2026 Earnings Significant EPS Miss Amid Challenging Coal Market Conditions YPF Q4 2025 Earnings Substantial Loss Reported Stock Climbs Amid Unusual Results AMPL Q1 2026 Earnings EPS Misses Estimates as Shares Rise Despite Challenging Quarter MCHP Q1 2026 Earnings EPS Beat Fails to Lift Stock as Revenue Concerns Linger NetEase Stock Declines Following Q1 Earnings Beat Market Reacts to Mixed Signals Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates